Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
Anthony Joseph DixonAthanassios KyrgidisHoward K SteinmanJohn B DixonMichael J SladdenClaus GarbeAimillios LallasChristopher B ZacharyUlrike LeiterHarvey Ronald SmithAlexander NirenbergChristos C ZouboulisCaterina LongoGiuseppe ArgenzianoZoi ApallaCatalin PopescuThrasyvoulos TzellosStuart AndersonLena NanzLloyd CleaverJ Meirion ThomasPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
is likely more appropriate. BAUSSS provides a more accurate melanoma-specific mortality risk assessment for patients without burdening them with added surgery, hospitalization, costs or morbidity risk.
Keyphrases
- sentinel lymph node
- risk assessment
- end stage renal disease
- cardiovascular events
- ejection fraction
- minimally invasive
- lymph node
- newly diagnosed
- chronic kidney disease
- early stage
- risk factors
- neoadjuvant chemotherapy
- coronary artery bypass
- high resolution
- squamous cell carcinoma
- heavy metals
- ultrasound guided
- skin cancer
- patient reported outcomes
- human health
- radiation therapy
- climate change
- percutaneous coronary intervention